Angiology
Protective Effects of PCSK9 Inhibitors on Renal Function in ASCVD Patients at High Risk for Contrast-Associated Acute Kidney Injury.
Lei Zha, Hui Fan, Jing Ma, Yong Deng, Yijie Song, Wei Mi, Yu Ma, Ximing Li
Published: 202510.1177/00033197251386109
Abstract
The present study explored the potential protective effects of a proprotein-converting enzyme subtilisin/kexin 9 inhibitor (evolocumab) against contrast-associated acute kidney injury (CA-AKI) in high-risk patients with atherosclerotic cardiovascular…
Preview only. Read the full abstract at the source